Clinical Scorecard: A preliminary randomized controlled study of a comprehensive intervention aimed at enhancing sexual function in women who have survived breast cancer

At a Glance

Key Highlights

• 30 participants completed the study with high adherence rates (92% for HRI, 90% for VMO)
• Improvements noted in sexual desire, body image, and GSM-related outcomes
• Large effect sizes observed for FSFI lubrication (d = 1.50) and pain reduction (d = 0.81)
• Combination of hypnotic relaxation and vaginal moisturizer shows promise for enhancing sexual function
• Feasibility of the intervention supports further research in larger studies

Guideline-Based Recommendations

Diagnosis

• Assess for vaginal dryness and pain during sexual activity
• Evaluate body image and sexual desire in breast cancer survivors

Management

• Implement non-hormonal vaginal moisturizers as first-line treatment for vaginal dryness
• Consider mind-body interventions like hypnotic relaxation for addressing psychological factors

Monitoring & Follow-up

• Track adherence to intervention protocols
• Evaluate changes in sexual function and body image over time

Risks

• Potential for inadequate addressing of psychological factors if only biological symptoms are treated
• Need for larger studies to confirm preliminary findings

Patient & Prescribing Data

Female breast cancer survivors with reported sexual health issues

Combination of hypnotic relaxation and vaginal moisturizer may enhance sexual function and body image

Clinical Best Practices

• Utilize a biopsychosocial approach to address sexual health in cancer survivors
• Incorporate both biological and psychological interventions in treatment plans
• Encourage open discussions about sexual health concerns with patients

Related Resources & Content

• ClinicalTrials.gov